{"id":"W2621574813","doi":"10.1634/theoncologist.2016-0455","title":"Bevacizumab for Metastatic Colorectal Cancer: A Global Cost-Effectiveness Analysis","year":2017,"lang":"en","type":"article","venue":"The Oncologist","topic":"Colorectal Cancer Treatments and Studies","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":true,"ca_institutions":"Canadian Centre for Applied Research in Cancer Control; Health Sciences Centre; Sunnybrook Health Science Centre","funders":"European Society for Medical Oncology; Clalit Health Services; Burroughs Wellcome Fund","keywords":"Medicine; Bevacizumab; Colorectal cancer; Incremental cost-effectiveness ratio; Quality-adjusted life year; Cost effectiveness; Cost-effectiveness analysis; Willingness to pay; Cost–benefit analysis; Adverse effect; Oncology; Demography; Internal medicine; Chemotherapy; Cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035129,0.0001706199,0.0006220611,0.00002898244,0.0008599423,0.00006724479,0.0002191874,0.00004114519,0.0000584066],"category_scores_gemma":[0.0003142011,0.00009540648,0.0003289923,0.0001702054,0.0004333345,0.00004704393,0.0001107746,0.00007305024,0.000007347367],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009444957,"about_ca_system_score_gemma":0.000214348,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.003385286,"about_ca_topic_score_gemma":0.01218398,"domain_scores_codex":[0.9990596,0.00007025433,0.0001578238,0.0002728571,0.0001606057,0.0002789015],"domain_scores_gemma":[0.9988903,0.0003109183,0.0001873944,0.0003875735,0.000152919,0.0000709296],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.01708466,0.001116425,0.6215522,0.0002200812,0.02318766,0.0001703416,0.000720642,0.0003838809,0.0002877734,0.002048471,0.002418002,0.3308099],"study_design_scores_gemma":[0.004551591,0.001655995,0.9756374,0.00002596624,0.008522592,0.00001719772,0.0002579838,0.0008971201,0.0003420365,0.0007048373,0.007248317,0.000138962],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9802601,0.001364171,0.0005303075,0.006716626,0.0003525401,0.002871797,0.0004669745,0.00005736265,0.007380148],"genre_scores_gemma":[0.9964966,0.0002089154,0.0002075819,0.0001435725,0.0001099654,0.002468313,0.00002310472,0.000008587575,0.0003333136],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3540852,"threshold_uncertainty_score":0.6798949,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0896050830222645,"score_gpt":0.4412394298392327,"score_spread":0.3516343468169682,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}